Armistice Capital, LLC Voyager Therapeutics, Inc. Call Options Transaction History
Armistice Capital, LLC
- $6.56 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VYGR
# of Institutions
123Shares Held
34.3MCall Options Held
12.9KPut Options Held
37.7K-
Black Rock Inc. New York, NY5.31MShares$17.5 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$12.9 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$10.6 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.57MShares$8.46 Million0.05% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.5MShares$4.92 Million0.0% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $127M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...